Villari v. Terminix International, Inc.

677 F. Supp. 330, 1987 U.S. Dist. LEXIS 5649
CourtDistrict Court, E.D. Pennsylvania
DecidedJune 24, 1987
DocketCiv. A. 85-1363
StatusPublished
Cited by3 cases

This text of 677 F. Supp. 330 (Villari v. Terminix International, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Villari v. Terminix International, Inc., 677 F. Supp. 330, 1987 U.S. Dist. LEXIS 5649 (E.D. Pa. 1987).

Opinion

MEMORANDUM

LOUIS H. POLLAK, District Judge.

This diversity action was brought by Leonard and Annette Villari, individually and on behalf of their minor children, against Terminix International, Inc. (“Ter-minix”), a coiporation in the business of pest control. Plaintiffs allege that Termi-nix contaminated their home with a hazardous termiticide in 1983. Their complaint is in multiple counts, and raises a number of distinct legal theories. Terminix has moved for partial summary judgment.

Pursuant to a contract with Leonard Vil-lari, Terminix treated the Villari family home at 911 Moore Street, Philadelphia, with various chemicals used for termite control over a period of years. The method of termite control employed by Terminix is to apply chemicals in such a way as to create a chemical barrier between the house and the soil on which it rests. The contract provided for annual reinspections and additional treatments when necessary to maintain the chemical barrier.

On October 17, 1983, a Terminix employee performed an additional treatment using a termiticide known as Aldrin. Aldrin, a chlorinated hydrocarbon, was approved by the federal Environmental Protection Agency for subsurface ground insertion for termite control. Federal scientific research agencies conducted studies of Aldrin in response to documentation of Aldrin contamination of military housing. 1 The National Academy of Sciences set an interim airborne level for Aldrin of one micro-gram per cubic foot of air. A toxicologist at Region III of the Environmental Protection Agency has concluded that although there is no proof that Aldrin is carcinogenic in humans, “prudent public health policy and reasonable scientific consideration enables me to conclude that aldrin should be *332 considered a cancer causing chemical in man.” Plaintiffs’ Exhibit 17. The state of New York has banned Aldrin for residential use, and Terminix no longer uses Aldrin.

In the course of treating the Villari residence, for reasons that are disputed, a quantity of Aldrin spilled into the Villaris’ basement. The Terminix employee made efforts to remove the puddle of Aldrin from the basement floor. Annette Villari testified that the employee used the family's household mops and rags, which were later used by Annette Villari elsewhere in the house.

Annette Villari testified that all members of the family suffered headaches, nausea, dizziness and general malaise in the month after the spill, but did not at the time connect their symptoms with the spill. The Villaris did, however, become concerned about the consequences of the spill for the bottles of homemade wine that were fermenting in their basement, and asked Ter-minix to test the wine. Several weeks later, the Villaris contacted state and federal environmental agencies; the agencies suggested that the Villaris arrange to have the air in their home tested as well. The Vil-laris commissioned air sampling tests, and informed Terminix that tests revealed a level of 8.7 micrograms of Aldrin per cubic meter of air.

A month after the spill, Terminix relocated the Villari family to two hotel rooms to permit Terminix to decontaminate the house pursuant to an agreement to reduce the Aldrin contamination to specified levels. Four months later, in April 1984, the Villaris were informed by Terminix’s insurance carrier that the clean-up was substantially complete and that their hotel expenses would no longer be paid. The Vil-laris had further tests performed in May 1984, and were not satisfied with the results of the clean-up. The Pennsylvania Department of Agriculture instructed Ter-minix by letter that, because the Villaris use their basement as a play area for their children, further clean-up was needed. For reasons that are disputed, the work was not performed.

The Villaris testified that these events placed considerable strain on family life. Crowded conditions in the hotel, and loss of the additional space their basement had provided, caused the family to decide that the two oldest children should live away from home. These circumstances, along with general fears of future medical problems due to Aldrin exposure, caused Mrs. Villari in particular to feel inadequate as a parent.

Terminix’s motion for partial summary judgment is based in part on questions of law and in part on challenges to the factual record after discovery. The motion shall be granted in part and denied in part.

I. Strict Products Liability

Count VII of the complaint states a claim for strict liability under section 402A of the Restatement (Second) of Torts. The Villaris allege that Terminix sold or distributed unreasonably dangerous insecticides and failed to warn the Villaris of the danger.

Terminix argues that this claim must fail because the Villaris cannot demonstrate that Aldrin is a defective product. We disagree. Under section 402A, a product may be defective because it fails to carry warnings concerning the risks of foreseeable improper uses. The Villaris have, in our view, presented sufficient evidence to permit a reasonable jury to infer that Aldrin is hazardous if inhaled, that Aldrin was introduced into their home without proper warnings as to that danger, and that Aldrin is defective as a product in the absence of proper warnings.

Terminix also argues that the Villaris have failed to produce sufficient evidence that they suffered physical harm as a result of their exposure to Aldrin. In her deposition testimony, Annette Villari stated that members of the Villari family suffered headaches, nausea, dizziness, and general malaise in the month after the spill. Dr. G. John DiGregorio, whose qualifications as an expert are unchallenged, issued a report in which he concluded that the symptoms suffered by the Villaris are consistent with the effects of exposure to Aldrin. We con- *333 elude that this evidence — although admittedly not as strong as contemporaneous diagnosis by a treating physician — is sufficient to permit a reasonable jury to conclude that the Villaris suffered physical harm as a result of Aldrin exposure.

Terminix also argues that it cannot be held liable under section 402A because it provided a service rather than a product. There is no doubt that Terminix supplied the termiticides it applied to the Villari residence. Indeed, the evidence reveals that Terminix, under contract with the manufacturer of Aldrin, was at the time of the spill the sole supplier of Aldrin in the United States. Put more precisely, then, Terminix’s argument is that one who supplies a product in the course of performing a service cannot be held liable under Restatement (Second) of Torts § 402A for defects in the product. Although the question is an unsettled one under Pennsylvania law, we conclude that the courts of Pennsylvania would, when faced with the issue, find liability in such circumstances under section 402A.

In Berkebile v. Brantly Helicopter Corp., 462 Pa. 83, 337 A.2d 893

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carll v. Terminix International Co., LP
793 A.2d 921 (Superior Court of Pennsylvania, 2002)
Malloy v. Doty Conveyor
820 F. Supp. 217 (E.D. Pennsylvania, 1993)
Karibjanian v. Thomas Jefferson University Hospital
717 F. Supp. 1081 (E.D. Pennsylvania, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
677 F. Supp. 330, 1987 U.S. Dist. LEXIS 5649, Counsel Stack Legal Research, https://law.counselstack.com/opinion/villari-v-terminix-international-inc-paed-1987.